1. Home
  2. News
  3. Kangmei Pharmaceutical Co., Ltd
  4. Announcement on Convening the Q3 2024 Performance Briefing
More Kangmei Pharmaceutical Co., Ltd news
Kangmei Pharmaceutical Co., LtdSSE: 600518

Announcement on Convening the Q3 2024 Performance Briefing

Nov 8, 2024 · Issued by Kangmei Pharmaceutical Co., Ltd via Shanghai Stock Exchange

Filed with SSE · Nov 8, 2024 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-39

Kangmei Pharmaceutical Co., Ltd on 6ix

Earlier from Kangmei Pharmaceutical

  • Announcement on Resolutions of the 3rd Extraordinary Meeting of the 9th Board of Supervisors in 2024Oct 31, 2024
  • Announcement on Progress of Litigation Enforcement by Subsidiaries (III)Oct 9, 2024
  • Announcement on Convening the 2024 Semi-annual Performance BriefingSep 6, 2024
  • Announcement on Resolution of the 6th Meeting of 9th Board of SupervisorsAug 24, 2024
  • Announcement on Progress of Litigation Enforcement by Subsidiaries (II)Aug 20, 2024

Later from Kangmei Pharmaceutical

  • Announcement on Abnormal Fluctuations in Stock TradingNov 9, 2024
  • Announcement on Risk Warning in Stock TradingNov 12, 2024
  • Announcement on Resolution of the 1st Extraordinary General Meeting in 2024Nov 16, 2024
  • Announcement on Resolutions of the 1st Extraordinary Meeting of the 9th Board of Supervisors in 2025Jan 24, 2025
  • Announcement on Resolution of the 1st Extraordinary General Meeting in 2025Feb 11, 2025
All Kangmei Pharmaceutical news releases↗

Follow Kangmei Pharmaceutical into a list and get an email when it puts out news.

Follow Kangmei Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer